Collage Bio is a pre-seed biotechnology company developing novel and proprietary RNA-based therapeutics. Our proprietary technology predominantly modulates disease-causing proteins through targeted gene silencing through novel small interfering RNA (siRNA) and antisense oligonucleotide (ASO) therapeutics. Collage Bio platform distinguishes itself by employing structurally unique compounds with a clinically validated, chemically modified nucleotide composition. This approach aims to provide enhanced efficacy, stability, and safety compared to existing oligonucleotide therapeutics.